Unlock instant, AI-driven research and patent intelligence for your innovation.

OX40 antibody as well as preparation method and application thereof

An antibody and affinity technology, applied in the field of OX40 antibody and its preparation, can solve the problems of small toxic side effects and high antibody titer

Inactive Publication Date: 2020-05-26
SHANGHAI PHARMAEXPLORER +1
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there is no better OX40 antibody that properly plays the role of regulating the immune system and is applied in tumor immunotherapy, and achieves the effect of high antibody titer and less toxic side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • OX40 antibody as well as preparation method and application thereof
  • OX40 antibody as well as preparation method and application thereof
  • OX40 antibody as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0304] The preparation method of the nucleic acid is a conventional preparation method in the art. Preferably, it includes the following steps: obtaining the nucleic acid molecule encoding the above-mentioned protein by gene cloning technology, or obtaining the nucleic acid molecule encoding the above-mentioned protein by artificial full-sequence synthesis .

[0305] Those skilled in the art know that substitutions, deletions, alterations, insertions or additions can be appropriately introduced into the base sequence encoding the amino acid sequence of the above protein to provide a polynucleotide homologue. The homologue of the polynucleotide in the present invention can be prepared by replacing, deleting or adding one or more bases in the gene encoding the protein sequence within the scope of maintaining antibody activity.

[0306] carrier

[0307] The invention also provides a recombinant expression vector comprising the nucleic acid.

[0308] The recombinant expression v...

Embodiment 1

[0378] The preparation of embodiment 1OX40 antibody

[0379] 1.1 Preparation of Immunogen A

[0380] The nucleotide sequence containing the amino acid sequence Leu29-Ala216 encoding the extracellular domain of the human OX40 protein (the human OX40 protein sequence is derived from the Uniprot database, and the protein sequence number is P43489) was cloned into the pTT5 vector carrying the human IgG Fc fragment (hFc) And prepare the plasmid according to the established standard molecular biology method, the specific method is referring to Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Second Edition (Plainview, New York: Cold Spring Harbor Laboratory Press). The prepared plasmid was transiently transfected into HEK293 cells (polyetherimide (PEI), purchased from Polysciences) and expanded for culture. After 4 days, the cell culture fluid was collected, and the cell components were removed by centrifugation to obtain the culture su...

Embodiment 2

[0397] Example 2 Production and Purification of Lead Antibody

[0398] The concentration of antibodies produced by hybridoma cells is low, only about 0.1-10 μg / mL, and the concentration varies greatly. Moreover, various proteins produced by cell culture in the culture medium and fetal bovine serum components contained in the culture medium have varying degrees of interference with many biological activity analysis methods, so small-scale (1-5 mg) antibody production and purification are required.

[0399] The hybridoma cells obtained in Example 1 were inoculated into T-75 cell culture flasks, and expanded with DMEM medium containing 10% FBS. When the growth state is good, the cell culture spinner bottle is inoculated, and the production medium (Hybridoma serum free medium, purchased from Invitrogen Company) containing 2.5% FBS (Low IgG) is used. Add 500mL of production medium to each 2L culture spinner bottle, and inoculate the cell density at 1.0×10 5 / mL. Close the bottle...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Cell densityaaaaaaaaaa
Login to View More

Abstract

The invention discloses an antibody targeting OX40 as well as a preparation method and an application of the antibody. Specifically, the invention discloses a novel mouse source or human mouse chimeric antibody targeting OX40. The invention also discloses a method for preparing the monoclonal antibody. The monoclonal antibody disclosed by the invention can be combined with an OX40 antigen with high specificity, has very high affinity and has remarkable anti-tumor activity and the like.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to an OX40 antibody and its preparation method and application. Background technique [0002] OX40 (also known as CD134, TNFRSF4 or ACT35) is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and is a type I transmembrane glycoprotein. OX40 is mainly expressed in activated CD4+T cells and CD8+T cells, regulatory T cells (Treg) and natural killer cells (NK). The ligand of OX40 in vivo is OX40L (also known as CD152 or TNFSF4), which exists in the form of a trimer. OX40 / OX40L signaling plays a very important role in the activation and proliferation of T cells. Studies have shown that OX40 antibody can effectively promote the activation and proliferation of T cells, block the immunosuppressive effect of Treg cells, and activate the immune system. [0003] Clinical sample studies have found that OX40 is expressed in tumor infiltrating lymphocytes (Tumor infiltr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/28C12N15/13C12N5/10A61K39/395A61P35/00A61P35/04
CPCC07K16/2878A61P35/00A61P35/04C12N2510/00C07K2317/24C07K2317/56C07K2317/73A61K2039/505A61P37/00C07K2317/92C07K2317/76C07K2317/34C07K2317/64A61K31/282A61K31/337A61K39/3955
Inventor 柴晓鹃辛文芳曹艳云徐辉张瑜夏珂段清杨达志刘礼乐
Owner SHANGHAI PHARMAEXPLORER